TICKER COVERAGE
$PFE
2 long-form articles and 0 pre-market mentions covering $PFE from AskMelon Research.
2 articles
FEATURE
Pfizer's 6% dividend leans on a $43B oncology bet and a GAAP payout near 130%
Pfizer just printed a clean beat — $14.45 billion in Q1 2026 revenue, up 5.4%, an adjusted EPS of $0.75 that topped consensus, and management reaffirming full-year guidance of $59.5–62.5 billion. Read…
FEATURE
AstraZeneca's 16% oncology engine is real — its 28% GAAP margin and a Beijing courtroom are the tax nobody prices
AstraZeneca closed Q1 2026 with $15.29 billion in revenue, up 8% at constant currency and 13% as reported, with an oncology franchise that grew 16% to $6.8 billion and now supplies 44% of the top line…